Vassyl Lonchyna to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Vassyl Lonchyna has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.022
-
Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol. 1995 Aug; 13(8):1880-92.
Score: 0.016
-
Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial. J Thorac Cardiovasc Surg. 1993 Jan; 105(1):97-104; discussion 104-6.
Score: 0.003
-
Primary lymphoma of the heart. Prolonged survival with early systemic therapy in a patient. Cancer. 1991 Nov 15; 68(10):2289-92.
Score: 0.003